UFC welterweight Bradley Scott was flagged by the United States Anti-Doping Agency (USADA) back on May 27, 2018. Now the agency has come forward with a sanction following the fighter’s failed drug test.
USADA has determined that Bradley Scott failed an in-competition drug test for the banned substance benzoylecgonine, a metabolite of cocaine. The fighter has since been issued a two-year suspension from the octagon.
Bradley Scott will be eligible to compete once again July 3, 2020. Check out USADA’s full statement on the failed drug test down below.
“USADA announced today that Bradley Scott, of Melksham Wiltshire, United Kingdom, has tested positive for a prohibited substance and accepted a two-year sanction for his violation under the UFC® Anti-Doping Program.
“Scott, 29, tested positive for benzoylecgonine, a metabolite of cocaine, as the result of a urine sample he provided in-competition on May 27, 2018, at Fight Night 130 in Liverpool, United Kingdom. Cocaine is a non-Specified Substance in the class of Stimulants and prohibited in-competition under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
“USADA conducted a thorough investigation into Scott’s case and determined Scott had not provided verifiable evidence regarding the circumstances that led to his positive test. Scott’s two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on July 3, 2018, the date his provisional suspension was imposed.
“Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.”
